Recent trends of HER-2 examination and a new strategy of trastuzumab therapy for primary and metastatic breast cancer

Breast Cancer. 2009;16(4):283. doi: 10.1007/s12282-009-0168-y.
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Neoplasm Metastasis
  • Receptor, ErbB-2 / analysis*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab